Recent major advances in cardiovascular pharmacotherapy
European Journal of Clinical Pharmacology(2018)
摘要
The field of cardiovascular pharmacotherapy remains extremely active. The aim of this review is to summarize the recent major advances in cardiovascular pharmacotherapy, with a focus on (1) the new approved drug for treatment of heart failure with reduced ejection fraction—sacubitril/valsartan; (2) proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors; (3) the novel reversal agents for non-vitamin K oral anticoagulants (NOACs); and finally, (4) new evidence on pharmacological treatment of coronary artery disease.
更多查看译文
关键词
Cardiovascular drugs, Systolic heart failure, Coronary artery disease, Hypercholesterolemia, Anticoagulation agents, Antidotes
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要